Posted by Chantel M. Contributed by US National Library of Medicine National Institutes of Health
In the study of "High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats" by Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ., posted in US National Library of Medicine National Institutes of Health, found that the reversal of thiamine deficiency by high-dose thiamine and S-benzoylthiamine monophosphate (benfotiamine) prevented the development of incipient nephropathy. Recently, we reported that high-dose thiamine (but not benfotiamine) countered diabetic dyslipidemia.
No comments:
Post a Comment